Comparing novel treatments in chronic spontaneous urticaria: A critical appraisal of Bruton's tyrosine kinase inhibitors versus anti‐cytokine biologics in clinical trials

Documenti analoghi

• CCL2/C–C chemokine receptor type 2‐mediated interactions among mast cells, basophils, and endothelial cells
  di: Maruša Rihar, et al.
  Pubblicazione: (2025)
• Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients
  di: Sophia Neisinger, et al.
  Pubblicazione: (2025)
• Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes
  di: Yora Mostmans, et al.
  Pubblicazione: (2024)
• Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study
  di: Clive Grattan, et al.
  Pubblicazione: (2025)
• Gut microbial alteration in chronic spontaneous urticaria unresponsive to second generation antihistamines and its correlation with disease characteristics‐ a cross‐sectional case‐control study
  di: Indrashis Podder, et al.
  Pubblicazione: (2025)